Doliver Advisors’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,372
Closed -$209K 163
2022
Q2
$209K Sell
4,372
-100
-2% -$4.64K 0.07% 147
2022
Q1
$237K Sell
4,472
-160
-3% -$8.42K 0.07% 149
2021
Q4
$230K Sell
4,632
-685
-13% -$40.4K 0.07% 141
2021
Q3
$354K Buy
5,317
+190
+4% +$14.8K 0.12% 126
2021
Q2
$471K Buy
5,127
+2,737
+115% +$270K 0.16% 91
2021
Q1
$291K Buy
+2,390
New +$397K 0.11% 106

Other funds holding PRLB

Doliver Advisors's PRLB Position: Q3 2022 in Review

Doliver Advisors sold out of Protolabs (PRLB) in Q3 2022, closing a stake of 4,372 shares — an estimated $209K sold.

Doliver Advisors first reported a position in PRLB in Q1 2021 and held it in 6 quarters. The position peaked at $471K in Q2 2021. 211 funds tracked by Wall St. Rank hold PRLB as of Q3 2022.

  • Doliver Advisors reported no remaining Protolabs position as of Q3 2022 after selling out during the quarter.
  • Doliver Advisors sold 4,372 Protolabs shares in Q3 2022, an estimated $209K.
  • Doliver Advisors first reported a position in Protolabs in Q1 2021 and held it in 6 quarters.
  • Doliver Advisors's Protolabs position peaked at $471K in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Protolabs as of Q3 2022.

Based on Doliver Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.